Aptorum Group Ltd (NASDAQ:APM)

15.78
Delayed Data
As of 3:57pm ET
 -0.1201 / -0.76%
Today’s Change
11.80
Today|||52-Week Range
33.28
+3.95%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$473.3M

Company Description

Aptorum Group Ltd. is a pharmaceutical company, which engages in the development and commercialization of therapeutic and diagnostic technologies. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The Non-Therapeutics segment encompasses the development of surgical robotics and medical devices; and the activities of AML Clinic. The company was founded by Ian Huen on September 13, 2010 and is headquartered in Hong Kong.

Contact Information

Aptorum Group Ltd.
17/F, Guangdong Investment Tower
Hong Kong -- --
P:(522) 117-6611
Investor Relations:

Employees

Shareholders

Other institutional0.03%
Mutual fund holders0.01%
Individual stakeholders--

Top Executives

There are no executives to display.